ADRB3 and benign prostatic hyperplasia: In men with persistent storage symptoms after the initial medical treatment for LUTS/BPH, an antimuscarinic drug or beta-3 adrenoceptor agonist is recommended for treatment of DO or DO+DU [24,25].